Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.

TitleThrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.
Publication TypeJournal Article
Year of Publication2018
AuthorsRanganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS
JournalMult Scler
Volume24
Issue4
Pagination553-554
Date Published2018 Apr
ISSN1477-0970
KeywordsAlemtuzumab, Humans, Interferon-beta, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Thrombocytopenia
DOI10.1177/1352458517719152
Alternate JournalMult Scler
PubMed ID28661221

Weill Cornell Medicine Neurology 525 E. 68th St.
PO Box 117
New York, NY 10065 Phone: (212) 746-6575